Carbon Monoxide Therapy Using Hybrid Carbon Monoxide-Releasing/Nrf2-Inducing Molecules through a Neuroprotective Lens
Carbon monoxide (CO) has long been known for its toxicity. However, in recent decades, new applications for CO as a therapeutic compound have been proposed, and multiple forms of CO therapy have since been developed and studied. Previous research has found that CO has a role as a gasotransmitter and...
Main Authors: | Flavia Cavicchioli, Izzy M. Cesarotti, Madison Fangman, Josh Lua, Raymond Hautamaki, Sylvain Doré |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Chemistry |
Subjects: | |
Online Access: | https://www.mdpi.com/2624-8549/3/3/57 |
Similar Items
-
3-Hydroxyflavones and 3-Hydroxy-4-oxoquinolines as Carbon Monoxide-Releasing Molecules
by: Tatiana Soboleva, et al.
Published: (2019-03-01) -
Hydrogen Sulfide and Carbon Monoxide Tolerance in Bacteria
by: Sofia S. Mendes, et al.
Published: (2021-05-01) -
Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells
by: Federica Sodano, et al.
Published: (2023-07-01) -
‘Carbon-Monoxide-Releasing Molecule-2 (CORM-2)’ Is a Misnomer: Ruthenium Toxicity, Not CO Release, Accounts for Its Antimicrobial Effects
by: Hannah M. Southam, et al.
Published: (2021-06-01) -
The effect of carbon monoxide on meiotic maturation of porcine oocytes
by: David Němeček, et al.
Published: (2021-03-01)